This page shows the latest Interleukin-11 inhibitor news and features for those working in and with pharma, biotech and healthcare.
Boehringer Ingelheim has added another platform in its fibrotic disease R&D, partnering with Enleofen on preclinical-stage interleukin-11 inhibitors with potential in non-alcoholic steatohepatitis (NASH). ... The German pharma group has acquired
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...